Press Releases
AtriCure Reports Fourth Quarter 2020 and Full Year 2020 Financial Results
February 23, 2021
MASON, Ohio --(BUSINESS WIRE)--Feb. 23, 2021-- AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced fourth quarter 2020 and full year 2020 financial results....
AtriCure to Participate at the SVB Leerink 10th Annual Global Healthcare Conference
February 10, 2021
MASON, Ohio --(BUSINESS WIRE)--Feb. 10, 2021-- AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that the company will be participating in the upcoming SVB Leerink 10 th Annual...
AtriCure to Announce Fourth Quarter and Full Year 2020 Financial Results
February 02, 2021
MASON, Ohio --(BUSINESS WIRE)--Feb. 2, 2021-- AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it will release its fourth quarter and full year 2020 financial results on Tuesday,...
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2020
January 11, 2021
Fourth quarter 2020 worldwide revenue of $57.7 million ( U.S. $47.4 million , International $10.3 million ) MASON, Ohio --(BUSINESS WIRE)--Jan. 11, 2021-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA)...
AtriCure Announces Labeling Expansion for Cryo Nerve Block Therapy
January 04, 2021
Expansion includes adolescent patients, as young as 12 years of age, who can benefit from cryo nerve block therapy during surgical procedures involving the chest wall. MASON, Ohio --(BUSINESS WIRE)--Jan. 4, 2021-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial...
AtriCure to Participate in the 39th Annual J.P. Morgan Healthcare Conference
December 14, 2020
MASON, Ohio --(BUSINESS WIRE)--Dec. 14, 2020-- AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that the company will be participating in the upcoming 39 th Annual J.P....
AtriCure to Participate in Upcoming Piper Sandler 32nd Annual Virtual Healthcare Conference
November 19, 2020
MASON, Ohio --(BUSINESS WIRE)--Nov. 19, 2020-- AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that the company will participate in the upcoming Piper Sandler 32 nd Annual Virtual...
AtriCure to Announce Third Quarter 2020 Financial Results
October 13, 2020
MASON, Ohio --(BUSINESS WIRE)--Oct. 13, 2020-- AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it will release its third quarter 2020 financial results on Thursday, November 5, 2020 ....
AtriCure to Participate at the Morgan Stanley 18th Annual Global Healthcare Conference
September 01, 2020
MASON, Ohio --(BUSINESS WIRE)--Sep. 1, 2020-- AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that the company will be participating in the upcoming Morgan Stanley 18 th Annual Global...
AtriCure Announces Angie Wirick as Chief Financial Officer
August 06, 2020
MASON, Ohio --(BUSINESS WIRE)--Aug. 6, 2020-- AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, announced today that Andy Wade is stepping down from the position of Chief Financial Officer (CFO) for personal...